Related Experiment Video
Updated: Apr 16, 2026
11:07
Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
Published on: April 29, 2015
13.2K
A Magnetically Driven Biodegradable Microsphere with Mass Production Capability for Subunit Vaccine Delivery and
1Department of Biomedical Engineering, City University of Hong Kong, 999077 Hong Kong, SAR, China.
ACS Applied Materials & Interfaces
|September 12, 2024
Summary
This study introduces ovalbumin@magnetic nanoparticles (OVA@MNPs) in gelatin methacryloyl (GelMA) microspheres (OMGMs) for improved subunit vaccine delivery. OMGMs enhance antigen delivery to lymph nodes, boosting immune responses and antitumor effects.
Area of Science:
- Immunotherapy
- Vaccine Delivery Systems
- Nanotechnology
Background:
- Subunit vaccines are promising for viral infections and cancer immunotherapy.
- Clinical use is limited by poor antigen delivery, rapid clearance, and low cellular uptake.
- Novel delivery systems are needed to enhance subunit vaccine efficacy.
Purpose of the Study:
- To develop a novel subunit vaccine delivery system using ovalbumin@magnetic nanoparticles (OVA@MNPs) encapsulated within biodegradable gelatin methacryloyl (GelMA) microspheres (OMGMs).
- To improve antigen delivery efficiency, lymphatic system targeting, and sustained release for enhanced immunotherapy.
- To evaluate the in vivo efficacy of OMGMs in a murine model for improved immune response and antitumor effects.
Main Methods:
- Fabrication of OVA@MNPs-loaded GelMA microspheres (OMGMs) using microfluidic droplet generation.
- Magnetic field-guided delivery of OMGMs to the lymphatic system.
- Assessment of antigen accumulation in lymph nodes and antigen-presenting cells.
- Evaluation of cellular and humoral immunity and antitumor effects in murine models.
Main Results:
- OMGMs demonstrated efficient magnetic targeting and accumulation of antigens in lymph nodes.
- Sustained release of antigens from biodegradable GelMA microspheres was observed.
- Enhanced cellular and humoral immune responses were induced by OMGMs.
- Significant antitumor effects were achieved with a single booster immunization using OMGMs.
Conclusions:
- OMGMs represent a practical and effective subunit vaccination approach.
- This system overcomes limitations in antigen delivery efficiency for subunit vaccines.
- OMGMs show promise for advanced immunotherapeutic strategies against cancer and viral infections.
Related Concept Videos
01:24Modified-Release Drug Delivery Systems: Site-Targeted
144
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
144
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
132
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
132
01:29Microorganisms in Medicine and Therapeutics
1.5K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.5K